Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study

BACKGROUND: Continuous intra-duodenal infusion of levodopa-carbidopa intestinal gel (LCIG) is a well-established therapy for patients with advanced Parkinson’s disease (PD) suffering from motor complications despite optimized treatment with oral dopaminomimetics. However, time to discontinuation of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Parkinsons Dis
Egile Nagusiak: Moes, Harmen R., Groenendal-Laurensse, Jerney W.M.J., Drent, Martje, Tissingh, Gerrit, van Laar, Teus
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: IOS Press 2020
Gaiak:
Research Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458507/
https://ncbi.nlm.nih.gov/pubmed/32675420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-201978
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak